Redline Bio Labs
    All research guides
    Synthetic Peptides7 min read

    ARA-290 (Cibinetide) Research Guide: Innate Repair Receptor Peptide

    ARA-290 is an 11-residue peptide derived from erythropoietin's B-helix that engages the innate repair receptor (IRR) — an EPO-receptor / βcR heterodimer — without erythropoietic activity.

    What is ARA-290?

    ARA-290 (Cibinetide) is a peptidomimetic of the B-helix of human erythropoietin, developed to isolate EPO's tissue-protective activity from its hematopoietic activity.

    Mechanism of action

    The peptide binds the innate repair receptor (IRR) — a heterodimer of EPO-R and the common β-chain (CD131) — expressed on injured cells. IRR activation drives anti-apoptotic, anti-inflammatory, and reparative signaling cascades. ARA-290 does not engage the EPO homodimer required for erythropoiesis.

    Sourcing & purity

    Research-grade material should be ≥99% pure by HPLC with peptide content confirmed via mass spectrometry. Redline Bio material ships with batch documentation; independent third-party COAs are published on the lab reports page as testing returns.

    Compliance reminder

    Sold and distributed for laboratory research use only. Not approved by the FDA for human consumption, diagnosis, treatment, or cure of any disease. Researchers are responsible for compliance with all applicable institutional, state, and federal regulations.

    Frequently asked questions

    What is ARA-290?

    ARA-290 (Cibinetide) is an 11-amino-acid pyroglutamate helix-B peptide derived from the B-helix of erythropoietin. It selectively engages the innate repair receptor (a heterodimer of EPO-R and the common β-chain / CD131) without activating the classical EPO homodimer.

    Why does that matter?

    Full-length EPO drives both tissue-protective and erythropoietic effects. ARA-290 retains only the tissue-protective arm, allowing sustained exposure in study models without polycythemia — the basis for its neuropathy and tissue-protection research profile.

    Published data?

    Clinical research has explored ARA-290 in small-fiber neuropathy (including sarcoidosis-associated), diabetic neuropathy, and post-surgical repair models.

    More synthetic peptides research

    For research use only. Redline Bio products are not intended for human consumption, diagnosis, treatment, or cure of any disease.
    Redline Bio Labs

    Premium research peptides for scientific and educational purposes only. Not for human consumption.

    Redline Bio Labs reviews on PeptidesLookupPepsReview P-Score

    All products are intended for laboratory research use only. Not for human consumption, medical, or veterinary use.

    This site does not provide medical advice. These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease.

    Orders are accepted only from purchasers 21 years of age or older who attest that they are a qualified researcher or an authorized representative of a research institution, and that all materials are for in vitro research use only and will not be used on humans or animals.

    Billing: Your card statement will show Redline Bio Labs for every order placed on this site. If you see a charge you do not recognize, email support@redlinebiolabs.com before contacting your bank.

    We do not market or sell products for human consumption or personal use.

    Customer Support: support@redlinebiolabs.com · redlinebiolabs@yahoo.com · Hours: Mon–Fri, 9:00 AM – 5:00 PM Central

    Complaints and abuse reports: support@redlinebiolabs.com — resolved within 7 business days.

    Redline Bio Labs · Pinnacle CRE LLC · 206A S Loop 336, PMB 304, Conroe, TX 77304

    © 2026 Redline Bio Labs. All rights reserved.